Evans, JR; Lawrenson, JG (2012). Evans, Jennifer R (บ.ก.). "Antioxidant vitamin and mineral supplements for preventing age-related macular degeneration". Cochrane Database Syst Rev. 6: CD000253. doi:10.1002/14651858.CD000253.pub3. PMID22696317.
Evans, JR; Lawrenson, JG (2012-11-14). "Antioxidant vitamin and mineral supplements for slowing the progression of age-related macular degeneration". The Cochrane Database of Systematic Reviews. 11: CD000254. doi:10.1002/14651858.CD000254.pub3. PMID23152201.
Glazer-Hockstein, C; Dunaief, JL (2006). "Could blue light-blocking lenses decrease the risk of age-related macular degeneration?". Retina. 26 (1): 1–4. doi:10.1097/00006982-200601000-00001. PMID16395131.
Margrain TH, Boulton M, Marshall J, Sliney DH (2004). "Do blue light filters confer protection against age-related macular degeneration?". Progress in Retinal and Eye Research. 23 (5): 523–31. doi:10.1016/j.preteyeres.2004.05.001. PMID15302349.
Maller, J; และคณะ (2006). "Common variation in three genes, including a noncoding variant in CFH, strongly influences risk of age-related macular degeneration". Nat. Genet. 38 (9): 1055–59. doi:10.1038/ng1873. PMID16936732.
Hughes, Anne E; Orr, Nick; Esfandiary, Hossein; Diaz-Torres, Martha; Goodship, Timothy; Chakravarthy, Usha (2006). "A common CFH haplotype, with deletion of CFHR1 and CFHR3, is associated with lower risk of age-related macular degeneration". Nature Genetics. 38 (10): 1173–77. doi:10.1038/ng1890. PMID16998489.
Fritsche, L. G.; Lauer, N.; Hartmann, A.; Stippa, S.; และคณะ (2010). "An imbalance of human complement regulatory proteins CFHR1, CFHR3 and factor H influences risk for age-related macular degeneration (AMD)". Human Molecular Genetics. 19 (23): 4694–4704. doi:10.1093/hmg/ddq399. PMID20843825.
Yates JR, Sepp T, Matharu BK, Khan JC, Thurlby DA, Shahid H, Clayton DG, Hayward C, Morgan J, Wright AF, Armbrecht AM, Dhillon B, Deary IJ, Redmond E, Bird AC, Moore AT (2007). "Complement C3 Variant and the Risk of Age-Related Macular Degeneration". N Engl J Med. 357 (6): 553–61. doi:10.1056/NEJMoa072618. PMID17634448.
Maller JB, Fagerness JA, Reynolds RC, Neale BM, Daly MJ, Seddon JM (2007). "Variation in Complement Factor 3 is Associated with Risk of Age-Related Macular Degeneration". Nature Genetics. 39 (10): 1200–1201. doi:10.1038/ng2131. PMID17767156.
Yang Z, Camp NJ, Sun H, Tong Z, Gibbs D, Cameron DJ, Chen H, Zhao Y, Pearson E, และคณะ (2006). "A variant of the HTRA1 gene increases susceptibility to age-related macular degeneration". Science. 314 (5801): 992–93. doi:10.1126/science.1133811. PMID17053109.
Dewan A, Liu M, Hartman S, และคณะ (2006). "HTRA1 Promoter Polymorphism in Wet Age-Related Macular Degeneration". Science. 314 (5801): 989–92. doi:10.1126/science.1133807. PMID17053108.
Udar N, Atilano SR, Memarzadeh M, Boyer D, Chwa M, Lu S (2009). "Mitochondrial DNA Haplogroups Associated with Age-Related Macular Degeneration". Invest Ophthalmol Vis Sci. 50 (6): 2966–74. doi:10.1167/iovs.08-2646. PMID19151382.
Haines JL, Hauser MA, Schmidt S, Scott WK, Olson LM, Gallins P (2005). "Complement factor H variant increases the risk of age-related macular degeneration". Science. 308 (5720): 419–21. doi:10.1126/science.1110359. PMID15761120.
Rohrer B, Long Q, Coughlin B, Renner B, Huang Y, Kunchithapautham K (2010). "A targeted inhibitor of the complement alternative pathway reduces RPE injury and angiogenesis in models of age-related macular degeneration". Adv Exp Med Biol. Advances in Experimental Medicine and Biology. 703: 137–49. doi:10.1007/978-1-4419-5635-4_10. ISBN978-1-4419-5634-7. PMID20711712.
Yates JR, Sepp T, Matharu BK, Khan JC, Thurlby DA, Shahid H (2007). "Complement C3 variant and the risk of age-related macular degeneration". NEJM. 357 (6): 553–61. doi:10.1056/NEJMoa072618. PMID17634448.
Fritsche LG, Loenhardt T, Janssen A, Fisher SA, Rivera A, Keilhauer CN (2008). "Age-related macular degeneration is associated with an unstable ARMS2 (LOC387715) mRNA DNA damage and repair in age-related macular degeneration". Nat. Genet. 40 (7): 892–96. doi:10.1038/ng.170.
Ferris, Frederick L.; Wilkinson, C.P.; Bird, Alan; Chakravarthy, Usha; Chew, Emily; Csaky, Karl; Sadda, SriniVas R. (2013). "Clinical Classification of Age-related Macular Degeneration". Ophthalmology. 120 (4): 844–851. doi:10.1016/j.ophtha.2012.10.036. ISSN0161-6420.
Thornton J, Edwards R, Mitchell P, Harrison RA, Buchan I, Kelly SP (2005). "Smoking and age-related macular degeneration: a review of association". Eye. 19 (9): 935–44. doi:10.1038/sj.eye.6701978. PMID16151432.
Tomany SC, Cruickshanks KJ, Klein R, Klein BE, Knudtson MD (2004). "Sunlight and the 10-year incidence of age-related maculopathy: the Beaver Dam Eye Study". Arch Ophthalmol. 122 (5): 750–7. doi:10.1001/archopht.122.5.750. PMID15136324.
Szaflik JP, Janik-Papis K, Synowiec E, Ksiazek D, Zaras M, Wozniak K (2009). "DNA damage and repair in age-related macular degeneration". Mutat Res. 669 (1–2): 167–76. doi:10.1016/j.mrfmmm.2009.06.008.
Owsley, Cynthia; McGwin, Gerald; Clark, Mark E.; Jackson, Gregory R.; Callahan, Michael A.; Kline, Lanning B.; Witherspoon, C. Douglas; Curcio, Christine A. (2016). "Delayed Rod-Mediated Dark Adaptation Is a Functional Biomarker for Incident Early Age-Related Macular Degeneration". Ophthalmology. 123 (2): 344–351. doi:10.1016/j.ophtha.2015.09.041. ISSN0161-6420.
Owsley, Cynthia (2015-10-30). "Delayed Rod-Mediated Dark Adaptation Is a Functional Biomarker for Incident Early Age-Related Macular Degeneration". Ophthalmology. 123: 344–51. doi:10.1016/j.ophtha.2015.09.041.
Chakravarthy, U; Harding, SP; Rogers, CA; Downes, SM; Lotery, AJ; Culliford, LA; Reeves, BC; on behalf of the IVAN study, investigators (2013-07-18). "Alternative treatments to inhibit VEGF in age-related choroidal neovascularisation: 2-year findings of the IVAN randomised controlled trial". Lancet. 382 (9900): 1258–67. doi:10.1016/S0140-6736(13)61501-9. PMID23870813.
Lindsley, K; Li, T; Ssemanda, E; Virgili, G; Dickersin, K (2016). "Interventions for Age-Related Macular Degeneration: Are Practice Guidelines Based on Systematic Reviews?". Ophthalmology. 123 (4): 884–97. doi:10.1016/j.ophtha.2015.12.004. PMID26804762.
Evans, JR; Lawrenson, JG (2012). Evans, Jennifer R (บ.ก.). "Antioxidant vitamin and mineral supplements for preventing age-related macular degeneration". Cochrane Database Syst Rev. 6: CD000253. doi:10.1002/14651858.CD000253.pub3. PMID22696317.
Evans, JR; Lawrenson, JG (2012-11-14). "Antioxidant vitamin and mineral supplements for slowing the progression of age-related macular degeneration". The Cochrane Database of Systematic Reviews. 11: CD000254. doi:10.1002/14651858.CD000254.pub3. PMID23152201.
Glazer-Hockstein, C; Dunaief, JL (2006). "Could blue light-blocking lenses decrease the risk of age-related macular degeneration?". Retina. 26 (1): 1–4. doi:10.1097/00006982-200601000-00001. PMID16395131.
Margrain TH, Boulton M, Marshall J, Sliney DH (2004). "Do blue light filters confer protection against age-related macular degeneration?". Progress in Retinal and Eye Research. 23 (5): 523–31. doi:10.1016/j.preteyeres.2004.05.001. PMID15302349.
Maller, J; และคณะ (2006). "Common variation in three genes, including a noncoding variant in CFH, strongly influences risk of age-related macular degeneration". Nat. Genet. 38 (9): 1055–59. doi:10.1038/ng1873. PMID16936732.
Hughes, Anne E; Orr, Nick; Esfandiary, Hossein; Diaz-Torres, Martha; Goodship, Timothy; Chakravarthy, Usha (2006). "A common CFH haplotype, with deletion of CFHR1 and CFHR3, is associated with lower risk of age-related macular degeneration". Nature Genetics. 38 (10): 1173–77. doi:10.1038/ng1890. PMID16998489.
Fritsche, L. G.; Lauer, N.; Hartmann, A.; Stippa, S.; และคณะ (2010). "An imbalance of human complement regulatory proteins CFHR1, CFHR3 and factor H influences risk for age-related macular degeneration (AMD)". Human Molecular Genetics. 19 (23): 4694–4704. doi:10.1093/hmg/ddq399. PMID20843825.
Yates JR, Sepp T, Matharu BK, Khan JC, Thurlby DA, Shahid H, Clayton DG, Hayward C, Morgan J, Wright AF, Armbrecht AM, Dhillon B, Deary IJ, Redmond E, Bird AC, Moore AT (2007). "Complement C3 Variant and the Risk of Age-Related Macular Degeneration". N Engl J Med. 357 (6): 553–61. doi:10.1056/NEJMoa072618. PMID17634448.
Maller JB, Fagerness JA, Reynolds RC, Neale BM, Daly MJ, Seddon JM (2007). "Variation in Complement Factor 3 is Associated with Risk of Age-Related Macular Degeneration". Nature Genetics. 39 (10): 1200–1201. doi:10.1038/ng2131. PMID17767156.
Yang Z, Camp NJ, Sun H, Tong Z, Gibbs D, Cameron DJ, Chen H, Zhao Y, Pearson E, และคณะ (2006). "A variant of the HTRA1 gene increases susceptibility to age-related macular degeneration". Science. 314 (5801): 992–93. doi:10.1126/science.1133811. PMID17053109.
Dewan A, Liu M, Hartman S, และคณะ (2006). "HTRA1 Promoter Polymorphism in Wet Age-Related Macular Degeneration". Science. 314 (5801): 989–92. doi:10.1126/science.1133807. PMID17053108.
Udar N, Atilano SR, Memarzadeh M, Boyer D, Chwa M, Lu S (2009). "Mitochondrial DNA Haplogroups Associated with Age-Related Macular Degeneration". Invest Ophthalmol Vis Sci. 50 (6): 2966–74. doi:10.1167/iovs.08-2646. PMID19151382.
Mullins RF, Russell SR, Anderson DH, Hageman GS (2000). "Drusen associated with aging and age-related macular degeneration contain proteins common to extracellular deposits associated with atherosclerosis, elastosis, amyloidosis, and dense deposit disease". FASEB J. 14 (7): 835–46. PMID10783137.
Chen LJ, Liu DT, Tam PO, Chan WM, Liu K, Chong KK (2006). "Association of complement factor H polymorphisms with exudative age-related macular degeneration". Mol. Vis. 12: 1536–42. PMID17167412.
Haines JL, Hauser MA, Schmidt S, Scott WK, Olson LM, Gallins P (2005). "Complement factor H variant increases the risk of age-related macular degeneration". Science. 308 (5720): 419–21. doi:10.1126/science.1110359. PMID15761120.
Rohrer B, Long Q, Coughlin B, Renner B, Huang Y, Kunchithapautham K (2010). "A targeted inhibitor of the complement alternative pathway reduces RPE injury and angiogenesis in models of age-related macular degeneration". Adv Exp Med Biol. Advances in Experimental Medicine and Biology. 703: 137–49. doi:10.1007/978-1-4419-5635-4_10. ISBN978-1-4419-5634-7. PMID20711712.
Thornton J, Edwards R, Mitchell P, Harrison RA, Buchan I, Kelly SP (2005). "Smoking and age-related macular degeneration: a review of association". Eye. 19 (9): 935–44. doi:10.1038/sj.eye.6701978. PMID16151432.
Tomany SC, Cruickshanks KJ, Klein R, Klein BE, Knudtson MD (2004). "Sunlight and the 10-year incidence of age-related maculopathy: the Beaver Dam Eye Study". Arch Ophthalmol. 122 (5): 750–7. doi:10.1001/archopht.122.5.750. PMID15136324.
Chakravarthy, U; Harding, SP; Rogers, CA; Downes, SM; Lotery, AJ; Culliford, LA; Reeves, BC; on behalf of the IVAN study, investigators (2013-07-18). "Alternative treatments to inhibit VEGF in age-related choroidal neovascularisation: 2-year findings of the IVAN randomised controlled trial". Lancet. 382 (9900): 1258–67. doi:10.1016/S0140-6736(13)61501-9. PMID23870813.
Lindsley, K; Li, T; Ssemanda, E; Virgili, G; Dickersin, K (2016). "Interventions for Age-Related Macular Degeneration: Are Practice Guidelines Based on Systematic Reviews?". Ophthalmology. 123 (4): 884–97. doi:10.1016/j.ophtha.2015.12.004. PMID26804762.
Mullins, RF; และคณะ (2000). "Drusen associated with aging and age-related macular degeneration contain proteins common to extracellular deposits associated with atherosclerosis, elastosis, amyloidosis, and dense deposit disease". FASEB J. 14 (7): 835–46. PMID10783137.
Janeway, CA Jr; Travers, P; Walport, M; และคณะ (2001). The complement system and innate immunity. Immunobiology: The Immune System in Health and Disease. New York: Garland Science.
Ferris, Frederick L.; Wilkinson, C.P.; Bird, Alan; Chakravarthy, Usha; Chew, Emily; Csaky, Karl; Sadda, SriniVas R. (2013). "Clinical Classification of Age-related Macular Degeneration". Ophthalmology. 120 (4): 844–851. doi:10.1016/j.ophtha.2012.10.036. ISSN0161-6420.
Owsley, Cynthia; McGwin, Gerald; Clark, Mark E.; Jackson, Gregory R.; Callahan, Michael A.; Kline, Lanning B.; Witherspoon, C. Douglas; Curcio, Christine A. (2016). "Delayed Rod-Mediated Dark Adaptation Is a Functional Biomarker for Incident Early Age-Related Macular Degeneration". Ophthalmology. 123 (2): 344–351. doi:10.1016/j.ophtha.2015.09.041. ISSN0161-6420.